Importance: Acanthamoeba is an increasingly prevalent cause of vision-threatening microbial keratitis.
INTRODUCTION
Acanthamoeba keratitis (AK) is an uncommon but potentially blinding infection of the cornea occurring predominantly in contact lens (CL) users. In patients presenting with AK, delayed diagnosis and treatment is associated with significantly poorer clinical and visual outcomes. 1, 2 Established infection typically requires a prolonged course of intensive treatment involving multiple clinic visits over several months. 3 The first ever published report of AK was from the United Kingdom in 1974, 4 and surprisingly the first case reported in New Zealand (NZ) was nearly two decades later (1990) . 5 There is significant geographic variation in the incidence of AK which is largely attributed to a number of risk factors linked to CL use, domestic water supply contamination, and exposure to contaminated water in swimming pools and hot tubs. 6, 7 Since first reported in NZ, the number of cases reported steadily increased up until 2008. 8, 9 Over the last 10 years anecdotal reports suggested the incidence may have further increased but has remained unconfirmed to date.
Given the relative rarity and short history of AK in New Zealand and elsewhere, an analysis of trends in presentation, diagnosis and outcomes over time can better characterize potential outbreaks and changes in incidence that are otherwise difficult to identify. A previous seven-year review of AK presenting to Auckland District Health Board (ADHB) from 2001 to 2008 noted an increasing incidence of AK attending this tertiary centre that was predominantly associated with CL use. 8 The current study is a second seven-year study assessing the incidence, presentation, diagnostic investigations and clinical outcomes of patients with AK in Auckland, New Zealand.
METHODS
This study was conducted in accordance with the NZ National Ethics Advisory Committee guidelines and the Declaration of Helsinki and met the criteria for exemption from formal Health and Disability Ethics Committee review. 10 All cases of AK presenting to the Eye Clinic, Greenlane Clinical Centre, ADHB were identified using a cross-referenced retrospective search of clinical, laboratory and pharmacy records from March 2009 to May 2016 inclusive. All cases were managed by one of four fellowship-trained corneal subspecialists within the tertiary cornea and external diseases service. Demographic and clinical data were collected from the clinical records and included age, gender, risk factors (CL use, using expired CLs or solutions, using CLs over the recommended duration, swimming/showering/sleeping with CLs in situ, cleaning CLs in tap or tank water, eye trauma), clinical symptoms and signs, initial diagnosis, diagnostic investigations, treatment, presenting and final best corrected visual acuity (BCVA) and surgical interventions. Mean presenting and final BCVA were calculated following conversion to LogMAR equivalent acuity as described elsewhere.
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Clinical photographs, laboratory reports, and in vivo confocal microscopy (IVCM) images were reviewed where available. The diagnosis of AK was confirmed by IVCM, laboratory microscopy, laboratory growth on culture, biopsy, or in a minority of cases characteristic clinical presentation combined with a positive response to treatment with antiamoebic topical therapy in the absence of any other positive diagnostic tests or microbiology for other causes of keratitis.
All data analysis and statistical calculations were completed using R statistical analysis software. 12 For variations in monthly and yearly incidence, ADHB data from August 2001 to May 2008 8 were included in the analysis to give an enhanced longitudinal view of AK incidence at the same centre.
RESULTS Demographics
Fifty-eight eyes of 52 patients were diagnosed with AK. Twenty-three patients were male (44.2%) and 29 patients were female (55.8%). Bilateral cases included three males and three females. The mean age was 36 years (range = 15-66 years, standard deviation = 11.8 years). First presentation of cases was most commonly to the general practitioner n = 17 patients (32%), the emergency eye clinic at Auckland Hospital (n = 14, 27%), community optometrist (n = 10, 19%), ophthalmologists from outside ADHB, that is, tertiary referrals (n = 6, 12%), and from ophthalmologist in private practice in the metropolitan area and elsewhere in New Zealand (n = 5, 10%).
Risk factors
CL use was noted in 96% of unilateral and 100% of bilateral cases of AK. The majority of CL use involved soft disposable CLs (48 eyes, 90%). This group consisted of monthly disposable CLs (29 eyes, 60.4%), weekly disposable CLs (6 eyes, 12.5%), daily disposable CLs (6 eyes, 12.5%), and disposable CLs (type unspecified) (7 eyes, 14.6%). Three cases involved rigid gas permeable lenses (one case in piggyback configuration with a soft CL), one case involved a hybrid CL and one case involved a cosmetic CL. CL users in the current study cohort were noted to have the following risk factors at, or directly preceding, the onset of symptoms: using disposable CLs beyond the manufacturer recommended duration (25%); swimming with CLs in situ (19%); showering or bathing with CLs in situ (12%), sleeping with CLs in situ (12%); using expired CL solution (6%); hot pool use with CLs in situ (6%); using stored tank (rain) water for cleaning CLs (4%) and eye trauma (2%).
Clinical features
The mean duration of symptoms at presentation was 21 days (five-number summary: [minimum, lower quartile, median, upper quartile, maximum] 1, 5, 14, 28, 120 days). The most common symptoms were: pain (n = 54, 93%); redness (n = 48, 83%); photophobia (n = 24, 41%); decreased vision (n = 20, 34%); watering (n = 15, 26%) and itch/foreign body sensation (n = 1, 2%). The most common clinical signs were: corneal epitheliopathy (n = 44, 76%); stromal infiltrate (n = 22, 40%); anterior chamber reaction (n = 17, 29%); corneal ulceration (n = 10, 17%); pseudo-dendrites (n = 8, 14%); neurokeratitis (n = 5, 9%), stromal ring infiltrate (n = 5, 9%); hypopyon (n = 3, 5%) and corneal thinning (n = 1, 2%). Epithelial involvement in AK is shown in Figure 1 . The mean and median presenting Snellen BCVA was 6/33 (95% confidence interval 6/20 to 6/54) and 6/15, respectively.
Preliminary diagnosis and empiric treatment
The provisional diagnosis prior to any investigations was recorded as CL-related keratitis in 41 eyes (70.6%), viral keratitis in nine eyes (15.5%), AK in seven eyes (12.0%) and peripheral ulcerative keratitis in one eye (1.7%). Topical empiric treatment was commenced immediately following the initial presentation in all cases. Combined ciprofloxacin and chloramphenicol was commenced in 24 eyes (41.4%), duotherapy with fortified cefuroxime in combination with gentamycin or tobramycin in 11 eyes (18.9%), ciprofloxacin monotherapy in 10 eyes (17.2%), topical acyclovir or ganciclovir (alone or in combination with an antibiotic) in nine eyes (15.5%), polyhexamethylene biguanide 0.02% and propamidine isethionate in four eyes (6.9%) and chloramphenicol monotherapy in two eyes (3.4%). Topical corticosteroid was commenced empirically (in combination with a topical antibiotic or antiviral agent) in six eyes (10.3%).
Investigations and diagnosis
Corneal scrape was completed at presentation prior to commencement of any treatment in 42 eyes (72.4%) and CL culture in an additional six eyes (10.3%). Positive microscopy or culture results for Acanthamoeba were noted in 13/48 laboratory samples (27.1%), with positive results reported at a mean of 9.4 days (five-number summary = 0, 4, 8, 15, 18 days). One case referred from another centre had positive corneal scrape results additionally confirmed by polymerase chain reaction, however, this test is not currently available at ADHB and was therefore not conducted for any other patients in the current study. Only one corneal scrape specimen positive for Acanthamoeba (8.3%) grew any other organism (in this case Cornyebacterium sp.). A total of seven corneal scrape samples (six falsely negative for Acanthamoeba) grew other organisms including Cladosporiium sp., Streptococcus mitis, Corynebacterium macginleyi and coagulase negative Staphlococcus sp. Six repeat corneal scrapes were completed following temporary cessation of antimicrobials when the initial corneal scrape specimen failed to identify any organisms. One of these repeat scrapes (16.7%) demonstrated a positive result for Acanthamoeba.
IVCM was completed in 47 eyes (81.0%) with 43% of scans completed within 48 h, 72% within 1 week, and 82% within 2 weeks following presentation. On IVCM imaging, Acanthamoeba was diagnosed by the presence of characteristic doublewalled cysts or signet rings. IVCM resulted in positive or strongly suggestive results for AK in 27 eyes (57.4%) and 12 eyes (25.5%), respectively with an overall total of 37 eyes (83.0%) with positive results. Inconclusive or negative IVCM results for AK were obtained in five eyes (10.6%) and three eyes (6.4%), respectively with an overall total of eight eyes (17.0%). In seven patients where the diagnosis remained unclear after the initial IVCM and corneal scrape results were inconclusive, an additional IVCM returned a positive result in four eyes (57%). IVCM diagnostic sensitivity with one scan alone was 83%, however, there were five cases where false positive IVCM results were noted and an alternative final diagnosis was confirmed by investigations and/or lack of response to antiamoebic therapy. There were a total of 27 eyes where the initial corneal scrape was negative and the IVCM was positive for AK. Overall the final diagnosis of AK was made on the basis of characteristic findings in IVCM alone in 37 eyes (63.8%); combined positive IVCM and corneal scrape results in six eyes (10.3%); positive corneal scrape results alone in six eyes (10.3%); positive corneal scrape and polymerase chain reaction in one eye (1.7%); positive CL culture in one eye (1.7%); clinical examination alone, in the context of bilateral keratitis and AK confirmed in the contralateral eye with IVCM or corneal scrape, in five eyes (8.6%); clinical examination alone in two eyes (5.2%).
The overall mean duration from presentation to definitive diagnosis using IVCM and or corneal scrape was 14 days (five-number summary = 0, 1, 4.5, 10, 146 days). In five patients (9%) diagnosis of AK was based on clinical features alone with all investigations failing to produce any positive results for alternative aetiology. These patients failed to respond to initial empiric antibacterial/viral treatment but did respond to antiamoebic therapy once commenced.
Herpes simplex virus (HSV) serology was tested in nine patients (17.3%) and was positive in five patients (55.6%) of those tested. Corneal biopsy was conducted in three eyes (5%) when all results were otherwise negative and the patient failed to respond to empiric treatment, one biopsy sample (33%) produced a positive result for AK.
Medical management
All patients were treated with standard dual antiamoebic therapy utilizing a biguanide such as polyhexamethylene biguanide (PHMB 0.02%), or chlorhexidine (0.02%), and a diamidine such as propamidine isethionate (Brolene). Topical treatment was commenced hourly for 48-72 h then titrated according to the clinical response for 3-12 months in total. In total 29 patients (55.8%) were admitted to hospital for intensive treatment and monitoring at the initial presentation and five patients required more than one hospital admission. The mean length of hospital stay was 6.3 days (five-number summary = 1, 3, 4, 8 and 29 days) for the initial admission and 10.3 days (range 2-18 days) for subsequent admissions. The mean number of outpatient clinic visits required until discharge was 10.1 (range 1-27). The mean duration of follow up was 262 days (five-number summary = 3, 114, 253.5, 362.25 and 907 days).
Surgical management
Surgical intervention was required in four patients, all of whom had a delayed diagnosis (mean = 93 days, range = 63-125 days). Three patients required elective optical penetrating keratoplasty following resolution of the infection and achieved final BCVA of 6/9-6/15 in the affected eye. One patient required an emergency tectonic penetrating keratoplasty following corneal perforation. This patient failed to improve despite the emergency corneal transplant and subsequently underwent enucleation.
Monthly and yearly incidence
Monthly and yearly variation in incidence of AK was observed as summarized in Figure 2 
Outcomes
Final BCVA was available for 47 patients (53 eyes) and demonstrated improvement from BCVA at presentation in 74%, remained unchanged in 9% and worsened in 17%. Final BCVA for AK eyes was recorded in 53 cases and was better than or equal to (cumulative results) 6/6 in 37%, 6/9 in 69%, 6/12 in 71%, 6/18 in 79%, 6/30 in 85% and 6/60 in 96%.
DISCUSSION
AK is a rare vision-threatening parasitic corneal infection and this study shows a recent increase in incidence in relation to cases treated at the major, tertiary, corneal service in NZ. A previous study spanning 7 years at the same centre from 2001 to 2008 reported 25 unilateral cases of AK with a mean rate of 3.6 cases per year. 8 The current study demonstrates a greater than two-fold increase in the mean incidence of AK with a mean rate of 8.3 cases per year in the same population, including six cases of bilateral AK. These observations, reflecting an increasing incidence of cases presenting with AK in NZ, are consistent with other studies noting similar increases in recent years in the United Kingdom, United States and Israel. 13, 14 CL use was the major risk factor for AK -present in 96% of unilateral and 100% of bilateral cases in the current study. The strong association between AK and CL use in the current study was similar to that in the preceding 7 years where CL use was documented in 96% of patients with AK. 8 Although most cases of AK were associated with monthly disposable CLs (60.4%), a significant number of AK cases were also observed with both weekly (12.5%) and daily (12.5%) disposable CLs. Poor CL hygiene, using expired solutions, and extending the life of disposable CLs beyond manufacturer specified durations are major risk factors for AK in the current study population. Half of the daily disposable CL users admitted to showering, sleeping or swimming in their CLs. These potentially modifiable risk factors may be linked to the increasing prevalence of online shopping where clinical examinations are less frequent and advice on CL hygiene may not be routinely provided or read when purchasing CLs via the internet. 15, 16 In the current study, bilateral AK was noted in six patients (11.5%) and all cases were associated with soft CL use. Bilateral AK is relatively rare with only a few reported cases in the literature all noting associated CL use. [17] [18] [19] [20] [21] [22] [23] [24] Most case reports of bilateral AK were associated with soft CL use with the largest case series involving bilateral AK in five patients in the USA, 19 however, one case has been previously reported involving rigid gas permeable CLs. 25 Although the risk of AK may be higher with certain types of CLs such as first generation silicone hydrogel CLs, 26 CLs of any sort constitute a significant risk factor for AK and include cosmetic and orthokeratology CLs [27] [28] [29] [30] as evidenced by the single case of cosmetic-CL related AK noted in the current study.
Clinical features of AK have been well described previously 31, 32 and are consistent with the clinical observations in this study. The most common clinical sign noted at presentation was corneal epitheliopathy, present in three quarters of all cases of AK. Other signs were also present to a lesser extent, including stromal infiltrate (40%); anterior chamber reaction (29%); corneal ulcer (17%); pseudodendrites (14%); neurokeratitis (9%), and stromal ring infiltrate (9%). The relative frequency of clinical signs noted at presentation in the current study were consistent with those noted in the preceding 7 years (epitheliopathy 64%, stromal infiltrate 56%, corneal ulcer 24% and neurokeratitis 12%). 8 The relatively reduced rate of clinical signs associated with advanced disease such as ring infiltrate (noted in 32% of patients in the preceding 7 years), is consistent with the relatively short duration of symptoms noted by most patients prior to presentation at ADHB (median = 14 days).
Corneal scrape was performed at presentation in approximately three quarters of all patients with AK but only produced positive results for AK in 27.1%. The effectiveness of isolating Acanthamoeba in cultures has been reported as between 30% and 60%. 33, 34 Despite the low sensitivity and long culture duration, debriding the epithelium at the time of scrape may be therapeutic in early AK by removing or reducing the total load of infective cysts and trophozoites. 1 In addition, rapid diagnosis was confirmed by microscopy in three cases in the current study (within 3 days), and in 16.7% of corneal scrapes superinfection with other organisms was identified -a common feature of AK noted in other reports 35, 36 and a potential cause of poor response to treatment if undetected. 37 Corneal biopsy was conducted in three cases and demonstrated positive results in one case (33%) consistent with a previous study reporting the sensitivity of corneal biopsy for the diagnosis of AK. 38 IVCM has high sensitivity and specificity for diagnosis of AK, with previous studies reporting sensitivity in excess of 90% -close to the sensitivity for IVCM noted in the current study.
1,37,39,40 Despite the benefits of immediate and non-invasive AK diagnosis, conducting and interpreting IVCM imaging with high reliability for diagnostic purposes requires an experienced operator who is familiar with the precise characteristic IVCM appearance of Acanthamoeba cysts and trophozoites. 41 The IVCM diagnostic criteria for AK in the current study were the presence of characteristic double-walled cysts or signet rings visible on IVCM images. Prompt diagnosis is critical in AK as delays in diagnosis are associated with poorer outcomes.
2 Timely access to IVCM for over 80% of patients in the current study was in part responsible for the relatively short duration from presentation to definitive diagnosis and appropriate treatment for the majority of patients with AK (mean = 14 days, median = 4.5 days). This time to diagnosis is significantly shorter than the time to diagnosis in the preceding 7 years (mean = 41 days, median = 21 days) and the corresponding mean visual outcomes of the entire current study cohort match those of the 'early diagnosis group' in the preceding study (i.e. mean BCVA of 6/12). 8 In cases where the laboratory or IVCM diagnosis was not possible, diagnosis was based on clinical features and positive response to antiamoebic therapy as described in other centres facing similar diagnostic challenges. 42 The use of empiric topical corticosteroid was relatively infrequently used as part of first-line treatment in the current study (10.3% of cases), and typically topical corticosteroid was not used even following commencement of antiamoebic therapy in most cases. Empiric corticosteroid treatment in the current study was associated with diagnostic delay. For the six eyes treated empirically with corticosteroids at presentation, the mean time to diagnosis was 47 days (range 15-154 days). Two were diagnosed with AK relatively quickly at 15 and 20 days and regained BCVA of 6/6. Diagnosis was significantly delayed in the remaining patients and resulted in significantly worse final BCVA ranging from 6/24 to perception of light. Corticosteroid use in AK is controversial and has been linked to proliferation of trophozoites, excystment and even late reoccurrence of AK. 37, 43 Corticosteroid treatment for AK is not recommended in the absence of antiamoebic therapy, or particularly in the presence of signs of aggressive disease such as a ring infiltrate. In these cases, corticosteroid use is associated with poor visual and clinical outcomes in AK. 44, 45 A recent study of 196 patients with AK demonstrated corticosteroid use in combination with antiamoebic therapy is not associated with worse outcomes and may help to control the significant inflammation associated with AK 1, 44 Despite this controversial evidence supporting the use of corticosteroid for some patients following commencement of antiamoebic therapy, avoiding the use of empiric corticosteroid by general ophthalmologists in a safe and prudent strategy that is likely to benefit most patients without exposing them to undue risk.
Three cases in the current study required surgical intervention -all three involved delayed diagnoses and required corneal transplantation. Delay in diagnosis is associated with an increased likelihood of requiring surgical management and worse visual outcomes. 2, 42, 46 In the current study, one case required an emergency tectonic corneal transplant for a perforated cornea and subsequently required enucleation due to persistent pain and a non-healing corneal ulcer. Therapeutic keratoplasty in the context of active infection is associated with multiple poor outcomes including the development of glaucoma, a 13-fold worse visual outcome, requirement for repeat transplantation, recurrence of infection and an increased number of follow up visits. 42, 47 The remaining three cases were conducted as elective optical corneal transplants following resolution of infection/inflammation. These three cases resulted in BCVA of 6/9-6/15 and one with 'perception of light' following a repeat keratoplasty, cyclodiode laser for intractable elevated intraocular pressure, and subsequent hypotony.
Patients who develop AK typically endure substantial morbidity that may last for several months despite intensive treatment, and suffer visual impairment that in many cases can be permanent. Diagnosis of AK is often challenging and when delayed is associated with worse outcomes. Clinicians should maintain a high index of suspicion for AK in CL users that develop keratitis. A corneal scrape should be completed at the initial presentation for any CL user with risk factors presenting with significant keratitis. Microbiology samples should be accompanied with a clearly documented request for urgent staining and microscopy to specifically exclude AK at the earliest opportunity. Timely access to IVCM may have in part mitigated some of the effects of the rising incidence of AK in the Auckland region over the past 7 years. To curb the rising incidence of AK, however, improved education regarding the CL-related risk factors is essential for all CL users.
